ALEXANDER LAZAR to Risk Assessment
This is a "connection" page, showing publications ALEXANDER LAZAR has written about Risk Assessment.
Connection Strength
0.145
-
Contemporary pathology of gastrointestinal stromal tumors. Hematol Oncol Clin North Am. 2009 Feb; 23(1):49-68, vii-viii.
Score: 0.034
-
Cumulative Incidence and Predictors of CNS Metastasis for Patients With American Joint Committee on Cancer 8th Edition Stage III Melanoma. J Clin Oncol. 2020 05 01; 38(13):1429-1441.
Score: 0.018
-
Extraskeletal Myxoid Chondrosarcomas: Combined Modality Therapy With Both Radiation and Surgery Improves Local Control. Am J Clin Oncol. 2019 10; 42(10):744-748.
Score: 0.018
-
Prognostic model for patient survival in primary anorectal mucosal melanoma: stage at presentation determines relevance of histopathologic features. Mod Pathol. 2020 03; 33(3):496-513.
Score: 0.017
-
Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial. Lancet Oncol. 2018 02; 19(2):181-193.
Score: 0.016
-
Risk assessment in solitary fibrous tumors: validation and refinement of a risk stratification model. Mod Pathol. 2017 10; 30(10):1433-1442.
Score: 0.015
-
Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model. Mod Pathol. 2012 Sep; 25(9):1298-306.
Score: 0.011
-
Protocol for the examination of specimens from patients with gastrointestinal stromal tumor. Arch Pathol Lab Med. 2010 Feb; 134(2):165-70.
Score: 0.009
-
Papulo-vesicular eruption. Dermatol Online J. 2007 May 01; 13(2):24.
Score: 0.007